Company Filing History:
1 out of 832,761 Years Active: 2001
Title: Larisa Sereda: Innovator in Genetic Diagnostics
Introduction
Larisa Sereda is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of genetic diagnostics, particularly in relation to collagen-related disorders. Her innovative work has the potential to impact the diagnosis and treatment of various pathological conditions.
Latest Patents
Larisa Sereda holds a patent for "Compositions and methods for detecting altered COL1A1 gene sequences." This patent describes compositions and methods useful for determining whether a subject has an alteration in a gene encoding a protein chain of Type I or Type IX collagen. The invention includes novel intronic sequences of five human genes: COL1A1, COL1A2, COL9A1, COL9A2, and COL9A3. The methods provided can determine the existence of pathological conditions associated with altered genes encoding Type I or Type IX collagen protein chains. These conditions include osteoporosis, osteoarthritis, chondrodysplasia, multiple epiphyseal dysplasia, osteogenesis imperfecta, shortness of stature, scoliosis, low bone density, and degenerative joint disease.
Career Highlights
Throughout her career, Larisa has focused on advancing genetic diagnostics. Her work has led to the development of methods that can detect genetic predispositions for various diseases. This innovative approach not only aids in diagnosis but also enhances prognostic capabilities for conditions associated with collagen deficiencies.
Collaborations
Larisa has collaborated with notable professionals in her field, including Darwin J Prockop and Loretta D Spotila. These collaborations have further enriched her research and contributed to the advancement of genetic diagnostics.
Conclusion
Larisa Sereda's contributions to the field of genetic diagnostics are invaluable. Her innovative patent on detecting altered COL1A1 gene sequences showcases her commitment to improving healthcare outcomes. Through her work, she continues to pave the way for advancements in the diagnosis and treatment of collagen-related disorders.